On the evening of 5 May, jeans (600436.SH) announced the upward adjustment of the retail price of jeans, which was once again raised by the company more than three years later.
In the announcement, jeans indicated that, in view of the major raw materials and the rising cost of manual jeans, the company had decided that, from the date of the announcement, the retail price of the domestic market for the company-led product of jeans would be transferred from 590 yuan renminbi to 760 yuan renminbi, with a corresponding upward adjustment in the price of supply of about 170 yuan renminbi; the overseas market supply price would be adjusted accordingly by about $35 /ap.
Acetylene is a liver-borne drug, whose function is to treat thermally detoxification, hypertension, indecency, and to provide for hepatitis, hypothetical hypertension, unnamed intoxication, drop-in injury and all kinds of pneumonia.
The company’s jeans product, which includes jeans, jeans and repulses, is dominated by jeans. In 2022, and in the first quarter of 2023, income from the sale of the jeans product ranged from $3,605 million to $1,371 million, with net profits of $2,233 million and $734 million, respectively.
In 2021, jeans in the end market were stagnated to yuan renminbi each, and a lip service was difficult. As a result of the destruction of the product, the business income of jeans in 2021 amounted to $8,022 million, an increase of 23.20 per cent, and the net profit attributable to shareholders of listed companies was $2,431 million, an increase of 45.46 per cent. The liver medicinal staple income of the jeans where the jeans are located amounts to 37.01 billion yuan, an increase of 45.75 per cent.
However, by 2022, the market had witnessed a “flag” in the form of jeans, a market that no longer ransomed and a product terminal return below 1,000 yuan renminbi. The overall performance of jeans has been significantly slowed down. Throughout 2022, the company achieved an operating income of $8,894 million, an increase of 8.38 per cent over the same period; the net profit attributable to shareholders of listed companies of $2,472 million, representing an increase of only 1.66 per cent over the same period. At the same time, the liver medicinal block income of the jeans in which they are located is £3592 million, a decrease of 2.95 per cent.
During the first quarter of 2023, jeans earned $2,630 billion in business income, an increase of 11.98 per cent over the same period; net profits belonging to shareholders of listed companies amounted to $770 million, an increase of 11.66 per cent. From this point of view, the net profit increase of companies is slightly lower than the growth rate of the company.
On that occasion, would the market accept an increase in the retail price of jeans on the initiative of jeans? It remains to be validated. In the announcement, jeans indicated that higher prices could result in a change in the volume of products in the jeans series. In line with past price adjustments, corporate business is generally growing steadily, but because market factors are more complex and do not exclude a decline in sales, corporate management will continue to work diligently to promote corporate performance through enhanced branding, market promotion, increased research and development inputs and enhanced channels.
Electricity information, precision reading, new waves